Legacy Education Inc.

Good day and welcome to the Legacy Education Third Quarter Fiscal 2025 Earnings Conference Call. Today's call is being recorded and broadcast live. It will also be archived on the Legacy Education website for future reference. To kick off the call, I will turn it over to Nicole Joseph, Senior Vice President of Legacy Education.

Thank you and hello everyone. Legacy Education has issued a news release reporting its financial results in corporate developments for the third quarter and nine months ended March 31, 2025. The release is available in the investor relations section of our corporate website at legacyed.com. With us today on the call are Leanne Roman, Chief Executive Officer and Brandon Pope, Chief Financial Officer. On today's earnings call, statements made by Legacy Management regarding the company's business, which are not historical facts, may be forward-looking statements as identified in federal security laws. The words may, will, expect, believe, anticipate, project, plan, intend, estimate and continue, as well as similar expressions are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance. The company cautions you that these statements reflect current expectations about the company's future performance or events and are subject to a number of uncertainties, risks and other influences, many of which are beyond the company's control that may influence the accuracy of the statements and projection upon which the statements are based. Factors that may affect the company's results include, but are not limited to, the risk and uncertainties discussed in the risk factor section of the annual report on form 10K and the quarterly report on form 10Q, filed with the Securities and Exchange Commission. Forward-looking statements are based on the information available at the time those statements are made and management's good faith belief as of the time with respect to future events. All forward-looking statements are qualified in their entirety by this cautionary statement and legacy undertakes no obligation to publicly revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, after the date thereof. I will now hand the call over to Leigh Ann Roman, CEO of Legacy Education, Leigh Ann to you. Thank you,

Nicole and good afternoon, everyone. I'm thrilled to welcome you to the Legacy Education third quarter fiscal 2025 earnings call. Joining me today is Brandon Pope, our Chief Financial Officer. We've had an outstanding quarter. I'm particularly proud to note that we've achieved double digit revenue growth for 11 consecutive quarters. And I'm excited to share our results, which reflect the strength of our business model, consistent execution, the dedication of our team and the growing demand of our career-focused healthcare education. Q3 was a record-breaking quarter for Legacy Education with revenue soaring .7% year over year to 18.6 million, driven by a remarkable .7% increase. A new student start and a .8% growth and ending enrollment, reaching 3,245 students as of March 31st, 2025. These results include the full quarter impact of our acquisition of Contra Costa Medical Career College, which added 468 students and expanded our footprint and high demand healthcare markets. We also surpassed a significant milestone, exceeding 3000 enrolled students as of January 31st, 2025. A testament to our team's execution and the value of our programs. Our focus on allied health education continues to resonate in a market hungry and desperate for skilled professionals. From nursing to diagnostic sonography, surgical technology to dental assisting, our programs are designated to meet employer needs, delivering graduates who are ready to fill critical workforce gaps. Our overall nursing NCLEX pass rate is 83%. We have an average of 75% placement rate through our accreditor asset and a 76% placement rate through our accreditor ABHES. These just underscore the quality of our education and the success of our students. Operationally, we've made significant strides. We've expanded our hybrid learning models, leveraging advanced simulation technology to enhance training while increasing student flexibility. Our six campuses across California and Lancaster, Bakersfield, Temecula, Salinas, Pasadena and Antioch are strategically located in areas with robust job growth and we're seeing strong enrollment trends across all locations. The integration of Contra Costa is progressing smoothly, unlocking new market opportunities and we're actively evaluating additional acquisition targets and branch locations to further expand our geographic and programmatic reach. Financially, we delivered robust profitability with net income of 2.8 million or 21 cents per diluted share and an adjusted EBITDA of 3.9 million, up 60% year over year. Our balance sheet remains strong with 17.3 million in cash and 22 million in working capital, providing ample liquidity to fuel organic growth, invest in new programs, add branches and pursue strategic acquisitions. Before I turn it over to Brandon for a deeper dive into the numbers, I want to thank our employees, our students, our shareholders and partners. Your belief in our sector and commitment drives our mission to empower students and address the healthcare workforce shortage. With that, I'll hand it over to Brandon Pope, our CFO, to walk you through our financial performance. Brandon.

Thank you, Ayan. I'm pleased to report another quarter of exceptional financial performance, reflecting our strong operational execution and the scalability of our business model. Let's dive into the key metrics for Q3 fiscal 25, ended March 31st, 2025, with comparison to Q3 24. The third quarter revenue reached 18.6 million, a .7% increase from 12.3 million last year. This growth was driven by a .8% increase in ending enrollment to 3,245 students and a .7% surge in new student starts from 719 to 1,227, including the impact of Contra Costa Medical College. Net income increased .1% to 2.8 million or 21 cents per due share compared to 1.8 million or 19 cents per due share in Q3 24. EBITDA rose 3.8 million and adjusted EBITDA, which excludes non-cash compensation, climbed 60% to 3.9 million from 2.4 million last year. Educational services were at 10.1 million or .4% of revenue compared to 6.5 million or .1% of revenue in Q3 24. The increase reflects investment in instructional staff, rent, externship fees in our RN program to support enrollment growth. General and administrative expenses were 4.6 million or .9% of revenue, up from 3.3 million or .8% of revenue last year, driven by higher marketing, professional fees and bad debt expense. Marketing expenses increased 1.2 million from 0.9 million, supporting our student acquisition effort. For the nine months ended March 31st, 2025, revenue grew 39% to 46.2 million from 33.2 million. Net income increased .9% to 6.3 million or 51 cents per due share compared to 4.2 million or 43 cents per due share. EBITDA was 8.3 million and adjusted EBITDA rose .2% to 8.6 million. These results reflect a .6% increase in new student starts at 2,473. Our liquidity remains robust at 17.3 million in cash and cash equivalents and 22 million in working capital as of March 31st, 2025. Total assets were 67.1 million and stock close equity stood at 39.3 million. Capital expenditures for nine months were 0.8 million, primarily for campus enhancements and technology upgrades. We generated 4.7 million in net cash from operating activity and our debt remains minimal at a million dollars, positioning us well for future investments. I'll now turn it back to Leigh Ann for strategic outlook and closing remarks.

Thank you, Brandon. As we look ahead, legacy education is poised for continued momentum. Our strategic priorities remain clear, driving enrollment growth, expanding our program offerings, optimizing operational efficiency and pursuing branching and accretive acquisitions. On enrollment, we're enhancing our marketing reach and deepening partnerships with healthcare employers to sustain strong student starts. Our data-driven outreach strategies and compelling value proposition are resonating as evidenced by our .7% increase in Q3 starts. We expect this trend to continue as we capitalize on the growing demand for healthcare professionals. Programmatically, we are adding existing programs to locations where there is high employer needs while we're also launching new offerings in high demand fields like sterile processing, surgical technician and EMT, completing our existing portfolio. These programs align with employer needs and leverage our advanced simulation technology and externship network to ensure graduate success. Operationally, we're focused on cost optimization while investing in technology and faculty to enhance the student experience. Our hybrid learning model supported by leading ed tech platform provides flexibility and scalability positioning us to reach more students efficiently. Our growth expansion plans through branching and our M&A strategy remain the key growth drivers. The successful integration of Contra Costa demonstrates our ability to execute accretive acquisitions. And we're actively evaluating opportunities to expand our geographic footprint and program diversity. With 17.3 million in cash and strong cash flow, we have the flexibility to act decisively. Regulatory dynamics continue to evolve but legacy is well positioned. Our focus on high demand allied health careers, strong placement rates and compliance with Title IV and accreditation standards gives us confidence and navigating the environment, employers urgent need for our graduates to reinforce the stability and the relevance of our business model. As we have moved, as we move into the final quarter of fiscal 2025, we are energized by our progress and the opportunities ahead. We're committed to empowering students, delivering value to our shareholders and solidifying legacy education as a leader in career focused education. I wanna turn it back over to the operator now to open up for Q&A.

Thank you. We will now be conducting a question and answer session. If you would like to ask a question, please press star one. The confirmation tone will indicate your line is in the question queue. If you would like to remove your question, please press star two. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. One moment please while we poll for questions. Thank you. Our first question comes from a line of Mike Gondal with Northland Securities. Please proceed.

Hey, thanks a lot. And Leanne and Brandon, congratulations on a really strong quarter. The quarter outperformance, can you talk a little bit about where that came from, whether it was specific campuses or specific programs?

Hi, Mike, great to hear from you. Absolutely. So in this quarter, like our top five programs remain strong in the medical assisting, the nursing, cardiac, UT and MRI. We specifically in the third quarter really saw our ability to be able to add some additional nursing classes as well as some imaging classes that led to just the fantastic quarter that we experienced.

Got it. So you would kind of say nursing and imaging is where a nice chunk of the upside came from?

Yes.

Got it.

And sure did.

Roughly in those additional classes you created, ballpark how many students you were able to fill?

So we added two additional classes in nursing, which led us to close to about 53 and then of those enrollments. And then in our imaging side, those cohorts, we set 20 at a time and we added an additional cohort in the imaging of 20.

Got it. That's great. April, May, any kind of early color on starts in that window?

Look at you. You just always wanna like push the envelope, don't you? Of course. Of course. Of course. You guys have a lot of momentum.

What

I would just remind all of you is that like in terms of in our business and your model is that we do have some, the seasonality. And we typically, our strongest quarters are the Q1 quarter and the Q3 quarter. Much like that you see Q2 and Q4, we do get impacted by seasonality.

Sure, sure. And then, hey, one more from me, Leanne and Brandon. CCMCC, it seems to be going really well. What does the acquisition pipeline look like? Are you working on anything, a couple things?

We do have a couple of the acquisition pipeline in our M&A that we are beyond just in conversations that we are looking at, but nothing more that we can really share at this time. But we definitely have a few that we are talking to.

Talking to a few, sounds great. Well, hey, congrats on a nice quarter.

Thank you. Thank you.

Thank you. Our next question comes from the line of Jeffrey Cohen with Landenberg Salmon. Please proceed.

Well, hi, Leanne and hi, Brandon. Thanks for taking our questions. I guess firstly, I'm gonna press a little on Mike's envelope with his question. And just reminding you that last year in 2024, your fourth quarter was actually slightly better than the third quarter on the top line. So can you help us frame that and how we should expect Q4? I know the consensus is probably on a down quarter, but it appears to me that the pull through is pretty strong from this quarter reported March.

Yeah, we had a great, this is Brandon. I'm glad you're taking a call. Yeah, Q3 is impacted by several things. If you remember, Q2 was a very 3% increase in starts only. Some of those starts came in in Q3. Similarly, in Q4, some of those starts that would typically show up in Q4 showed up in Q3 this year. And so that enhances our robust start for Q3. Q4, similar seasonality, probably a little less than Q4 of last year.

Okay, similar seasonality on an adding basis.

Yes, yeah. You're gonna see a different seasonality this year than you've seen typically based upon what I just mentioned. And it all depends on when the starts happen in that quarter and they typically happen in what quarter. When a student, when the course ends, another one begins, those kinds of things impact seasonality. There's a general seasonality and there's more specific seasonality. We're gonna see that general seasonality in Q4.

Okay, got it. Program wise, could you comment about the EMT program as far as number of campuses or number of classes that are existing now and duration and population size specific for EMT?

Right, sure. The EMT program right now is approved in our HDMC locations and so we have launched it in our Temecula campus right now only. It is a 12 week long course and we are teaching it primarily on the weekends. We are geared up to now roll it out among the rest of the HDMC campuses first with quickly to follow in our Pasadena campus and Salinas campus. What we wait for here is not only do we need the state approvals but we also need county approvals. And so as we're obtaining those county approvals, that's when we can start rolling those classes out in those locations where we have the approvals.

Super, that's helpful. Leigh Ann, did you call out anything related to neuro or neurology as far as any classes that you offer, any programs there to date?

No, not to date. We are doing some research in those in terms of new programs but we don't have any of those at this point.

Okay, and it sounds like on the M&A front, similar status that you'll keep us posted on anything that gets to some stage of telling us.

Yes.

Okay, perfect. That does it for us. Fantastic order, nice metrics.

Thanks, Jeff. Thank you. Good to hear from you.

Thank you. As there are no further questions, I'll now turn the call back over to Leigh Ann Romance for closing remarks.

Thank you, operator, and thank you all for joining us today. As we reflect on our third quarter results, as I previously stated, I'm incredibly proud of what we've achieved. Not just this quarter but over the past 11 quarters of the double digit growth. This consistent performance underscores the strength of our strategy and the critical role we play in addressing the healthcare workforce shortage. At Legacy Education, we are more than just an educational institution. We're a catalyst for change, empowering students to build rewarding careers and helping employers meet their staffing needs with skilled professionals. Our commitment to excellence, innovation, and student success drives us forward. I'm confident that this momentum will continue as we pursue new opportunities, expand our programs, and explore strategic acquisitions. I wanna express my deepest and sincere gratitude to our dedicated faculty and staff, whose hard work and passion make our success possible. To our students, thank you, thank you, thank you for choosing Legacy Education as your partner and achieving your dreams. And to our shareholders, thank you for your continued support and belief in our vision. We look forward to sharing more updates with you in the future and to continuing our journey of growth and impact. I hope you have a wonderful rest of the day and thank you again for being part of the Legacy Education story. Back to you, operator.

This concludes today's Legacy Education third quarter fiscal 2025 earnings conference call. Thank you for joining us and have a great day.